NCT07196605 - Sodium Sivelestat With Mechanical Thrombectomy for Acute Stroke: A Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions

Acute Ischemic StrokeNeutrophil Extracellular Traps FormationLarge Vessel OcclusionThrombectomy

Interventions

DRUG

Sodium Sivelestat

For enrolled patients, administer intravenous sodium sivelestat as soon as possible (recommended within 2 hours). The daily dosage is 4.8 mg/kg, delivered via continuous infusion with a microinfusion pump or intravenous drip, for a total duration of 5 days

Trial Locations (1)

100053

Xuanwu Hospital, Capital Medical University., Beijing

All Listed Sponsors

lead

Xuanwu Hospital, Beijing

OTHER